Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
This study has been terminated.
(Higher hemorrhage rates of Abciximab in ABESST II trial)
Sponsor:
University of Zurich
Collaborators:
Schweizerische Herzstiftung
Eli Lilly and Company
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00126139
First received: July 29, 2005
Last updated: May 1, 2007
Last verified: May 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | May 2005 |
| Estimated Primary Completion Date: | No date given |